{"id":"W2513184125","doi":"10.1016/j.jaci.2016.06.021","title":"Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study","year":2016,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":450,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"NIHR Sheffield Biomedical Research Centre; NIHR Cambridge Biomedical Research Centre; Medical Research Council; Novartis Institutes for BioMedical Research; University College London Hospitals NHS Foundation Trust; King's College London; Centre National de la Recherche Scientifique; Ligue Contre le Cancer; Bundesministerium für Bildung und Forschung; CSL Behring; National Institute for Health and Care Research; University of Cambridge; Biotechnology and Biological Sciences Research Council; University College London; Wellcome Trust; Cancer Research UK; Immunodeficiency Canada; Fondation ARC pour la Recherche sur le Cancer; Grifols; Agence Nationale de la Recherche; Regeneron Pharmaceuticals; Japan Blood Products Organization; Deutsches Zentrum für Infektionsforschung; Deutsche Forschungsgemeinschaft; Directorate for Biological Sciences; GlaxoSmithKline; Pfizer; Biogen; European Commission; Sanofi; Baxalta; Genentech; British Lung Foundation","keywords":"Cohort; Medicine; Phosphoinositide 3-kinase; Internal medicine; PI3K/AKT/mTOR pathway; Signal transduction; Biology; Genetics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00912291260241303,"score_gpt":0.2806859536634672,"score_spread":0.2715630410610541,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}